Login to Your Account



Biogen Reports Strong 2Q; Avonex Sales Beat Estimates

By Peter Winter
BioWorld Insight Editor

Wednesday, July 25, 2012
Biogen Idec Inc. soundly beat earnings estimates for the quarter by more than 16 percent. The company reported adjusted net income of $1.82 per share and Wall Street was looking for $1.56 per share.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription